
COVID-19 Roundup: Importance of Vaccine Uptake in Winter, Obesity’s Link with Long COVID
Catch up on important COVID-19 news from November 2024.
Ruth Carrico, PhD, DNP, APRN, Professor at the University of Louisville’s Division of Infectious Disease and co-founder of the Infection Prevention Institute, has partnered with Sanofi to talk about the importance of annual flu vaccination and address individuals that are particularly at risk.
Children and young adults with overweight or obesity may be at a significantly increased risk of developing long COVID, according to research published in JAMA Network Open. The authors of the study said the findings highlight the need for targeted care to prevent chronic conditions in at-risk pediatric patients.
Receiving a COVID-19 vaccine could reduce the risk of developing long COVID if it’s administered 5 months before an infection, according to new research published in the journal Vaccine. The authors of the study said that the findings could help with the formulation of future vaccination strategies as COVID-19 becomes endemic.
Trusting the science behind COVID-19 vaccines is a key factor for vaccine acceptance in the United States and indicates the willingness individuals have of getting booster shots, according to research published in the journal Vaccine: X. The authors of the study said trust in public health sources must be strengthened for the public to have confidence in vaccine programs.
The COVID-19 pandemic significantly affected the outcomes and health care access for individuals with pancreatic cancer living in England from January 2015 through March 2023, according to a study published in eLife Sciences. The authors said the findings suggest that if a similar public health crisis were to arise in the future, health care services should focus on the unmet needs of patients with cancer.
The current approach to managing long COVID with medications largely targets nervous system symptoms and carries significant risks associated with polypharmacy and drug-drug interactions, according to recent research published in the Journal of the American Pharmacists Association. The authors of the study said the findings highlight the need to enhance the safety of long COVID symptom management.
There is no association between timing of COVID-19 diagnosis and progression of atrial fibrillation in patients with new onset atrial fibrillation, according to research data presented at the American Heart Association’s 2024 Scientific Sessions, held November 16 to 18 in Chicago, Illinois. The authors said the findings do not support the notion that early COVID-19 diagnosis increases the likelihood of atrial fibrillation progression.
READ MORE:
Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Sign up today for our
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.




















































































































































